-V Lorusso Researcher Activity Profile

Research Author Detailed Information 

V Lorusso Publication Rate By Year

V Lorusso has published 1 paper(s) in 1997, 1 paper(s) in 2004, 6 paper(s) in 2005, 4 paper(s) in 2006, 3 paper(s) in 2007, 3 paper(s) in 2008, for a total of 18 research publications in total.

V V Lorusso Author Information

LAST NAME: lorusso

FIRST NAME: V

INITIALS: v

AFFILIATION:

Papers

V Lorusso's Publication Record

1. Biomarkers predictive for clinical efficacy of taxol-based chemotherapy in advanced breast cancer. Year Published: 2005
Clinical Experimental Oncology Laboratory, Histopathology Service, Medical Oncology Unit, Women's Department, National Cancer Institute, via Amendola 209, 70125 Bari, Italy.
2. Systemic chemotherapy for patients with advanced and metastatic bladder cancer: current status and future directions. Year Published: 2005
Operative Unit of Medical Oncology, Oncology Institute of Bari.
3. Clinical Evidence Supporting the Role of Lonidamine for the Treatment of BPH. Year Published: 2006
4. Effects of iodinated contrast media on endothelium: An in vitro study. Year Published: 2007
Bracco Imaging S.p.A, Milan Research Centre, Pharmacological Department, Via Egidio Folli, 50, 20134 Milan, Italy.
5. Escherichia coli O26 in minced beef: prevalence, characterization and antimicrobial resistance pattern. Year Published: 2007
Department of Health and Animal Welfare-Faculty of Veterinary Medicine-Str. Prov. per Casamassima Km 3, 70010 Valenzano (Ba), Italy.
6. Year Published: 2007
7. Oral vinorelbine plus capecitabine (oral vincap) combination in patients with advanced breast cancer (ABC). A phase II study of the GOIM (Gruppo Oncologico dell'Italia Meridionale). Year Published: 2006
Medical Oncology Unit, Vito Fazzi Hospital, Lecce. vitolorusso@inwind.it
8. Biomarkers predictive for clinical efficacy of taxol-based chemotherapy in advanced breast cancer. Year Published: 2005
Clinical Experimental Oncology Laboratory, National Cancer Institute, via Amendola 209, 70125 Bari, Italy. a.paradiso@oncologico.bari.it
9. Systemic chemotherapy for patients with advanced and metastatic bladder cancer: current status and future directions. Year Published: 2005
Operative Unit of Medical Oncology, Oncology Institute of Bari, Bari, Italy.
10. Oral vinorelbine plus capecitabine (oral vincap) combination in patients with advanced breast cancer (ABC). A phase II study of the GOIM (Gruppo Oncologico dell'Italia Meridionale). Year Published: 2006
Medical Oncology Unit, Vito Fazzi Hospital, Lecce. vitolorusso@inwind.it
11. Biomarkers predictive for clinical efficacy of taxol-based chemotherapy in advanced breast cancer. Year Published: 2005
Clinical Experimental Oncology Laboratory, National Cancer Institute, via Amendola 209, 70125 Bari, Italy. a.paradiso@oncologico.bari.it
12. Systemic chemotherapy for patients with advanced and metastatic bladder cancer: current status and future directions. Year Published: 2005
Operative Unit of Medical Oncology, Oncology Institute of Bari, Bari, Italy.
13. Darbepoetin alpha coming of age. Year Published: 2008
Falck Medical Oncology Unit, Niguarda Ca' Granda Hospital, Milano, Italy.
14. Oral vinorelbine plus capecitabine (oral vincap) combination in patients with advanced breast cancer (ABC). A phase II study of the GOIM (Gruppo Oncologico dell'Italia Meridionale). Year Published: 2006
Medical Oncology Unit, Vito Fazzi Hospital, Lecce. vitolorusso@inwind.it
15. Radiofrequency ablation of 40 lung neoplasms: preliminary results. Year Published: 2004
Unità Operativa di Radiologia Interventistica, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Oncologico, Via Amendola 209, Bari 70126, Italy.
16. Hepatocyte-directed MR contrast agents. Can we take advantage of bile acids? Year Published: 1997
Milano Research Center, Bracco SpA, Milan, Italy.
17. Is irinotecan plus docetaxel useful as second-line therapy in advanced non-small cell lung cancer? Year Published: 2008
Medical Oncology Unit 2, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
18. Contrast-enhanced MRI of murine sponge model for progressive angiogenesis assessed with gadoteridol (ProHance) and gadocoletic acid trisodium salt (B22956/1). Year Published: 2008
Pharmacological Department, Bracco Imaging SpA, Milan Research Centre, Milan, Italy.